|
|
|
Insider
Information: |
Keating Laurie |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
23,298 |
|
Indirect Shares
|
434 |
|
|
Direct
Value |
$1,302,314 |
|
|
Indirect Value
|
$104,225 |
|
|
Total
Shares |
23,732 |
|
|
Total
Value |
$1,406,539 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Alnylam Pharmaceuticals Inc |
ALNY |
EVP, Chief Legal Officer |
2021-08-05 |
5,132 |
2021-08-05 |
434 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Immuneering Corp |
IMRX |
|
2022-05-16 |
14,000 |
2021-08-03 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Pepgen Inc. |
PEPG |
Director |
2022-05-06 |
4,166 |
2022-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2020-01-27 |
4 |
OE |
$42.22 |
$1,451,270 |
D/D |
34,374 |
49,632 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
EVP, Chief Legal Officer |
|
2020-07-13 |
4 |
OE |
$42.22 |
$3,116,066 |
D/D |
35,750 |
50,242 |
0 |
- |
|
52 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|